Lucid Diagnostics Management
Management criteria checks 4/4
Lucid Diagnostics' CEO is Lishan Aklog, appointed in Oct 2021, has a tenure of 2.58 years. total yearly compensation is $300.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 1.25% of the company’s shares, worth $643.13K. The average tenure of the management team and the board of directors is 2.2 years and 6 years respectively.
Key information
Lishan Aklog
Chief executive officer
US$300.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 2.6yrs |
| CEO ownership | 1.3% |
| Management average tenure | 2.2yrs |
| Board average tenure | 6yrs |
Recent management updates
Recent updates
We're A Little Worried About Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate
May 09
Lucid Diagnostics (NASDAQ:LUCD) Will Have To Spend Its Cash Wisely
Dec 15Lucid Diagnostics launches stage II lucid test center in California, Texas, Florida, and Ohio
Aug 11We're Keeping An Eye On Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate
Jul 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$300k | US$300k | -US$53m |
| Sep 30 2023 | n/a | n/a | -US$57m |
| Jun 30 2023 | n/a | n/a | -US$57m |
| Mar 31 2023 | n/a | n/a | -US$60m |
| Dec 31 2022 | US$456k | n/a | -US$56m |
| Sep 30 2022 | n/a | n/a | -US$53m |
| Jun 30 2022 | n/a | n/a | -US$45m |
| Mar 31 2022 | n/a | n/a | -US$37m |
| Dec 31 2021 | US$7m | n/a | -US$28m |
Compensation vs Market: Lishan's total compensation ($USD300.00K) is below average for companies of similar size in the US market ($USD663.07K).
Compensation vs Earnings: Lishan's compensation has been consistent with company performance over the past year.
CEO
Lishan Aklog (57 yo)
2.6yrs
Tenure
US$300,000
Compensation
Dr. Lishan Aklog, M.D., serves as Executive Chairman at Veris Health Inc. since April 2023. He served as Independent Director at ContraFect Corporation since June 14, 2020 until December 04, 2023. Dr. Aklo...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 2.6yrs | US$300.00k | 1.25% $ 643.1k | |
| President & COO | 2.2yrs | US$162.50k | 0.24% $ 123.6k | |
| Chief Financial Officer | 6yrs | US$225.00k | 1.25% $ 643.1k | |
| General Counsel & Secretary | 2yrs | US$250.00k | no data | |
| Cofounder & Strategic Advisor | no data | US$924.54k | no data | |
| Cofounder | no data | no data | no data | |
| Cofounder | no data | no data | no data | |
| Chief Technology Officer | no data | no data | no data | |
| Chief Scientific Officer | 2.6yrs | no data | no data | |
| Chief Compliance Officer | no data | no data | 0.094% $ 48.1k | |
| Chief Regulatory & Quality Officer | less than a year | no data | no data | |
| Chief Medical Officer | 1.1yrs | no data | no data |
2.2yrs
Average Tenure
57yo
Average Age
Experienced Management: LUCD's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 6yrs | US$300.00k | 1.25% $ 643.1k | |
| Cofounder & Strategic Advisor | 3.3yrs | US$924.54k | no data | |
| Cofounder | 3.3yrs | no data | no data | |
| Cofounder | 6yrs | no data | no data | |
| Independent Vice Chairman of the Board & Lead Independent Director | 2.8yrs | US$214.75k | 0.20% $ 104.6k | |
| Independent Director | 3.3yrs | US$262.25k | 0.18% $ 91.1k | |
| Independent Director | 3.1yrs | US$252.25k | 0.18% $ 91.1k | |
| Independent Director | 6yrs | US$227.75k | 0.35% $ 178.3k | |
| Member of Medical Advisory Board | 6yrs | no data | no data | |
| Chair of Medical Advisory Board | 6yrs | no data | no data | |
| Member of Medical Advisory Board | 6yrs | no data | no data | |
| Member of Medical Advisory Board | 6yrs | no data | no data |
6.0yrs
Average Tenure
68yo
Average Age
Experienced Board: LUCD's board of directors are considered experienced (6 years average tenure).